Donna Salzman M.D.

Donna Salzman M.D.
Professor

Senior Scientist, Experimental Therapeutics , O'Neal Comprehensive Cancer Center
Professor (P), Medicine - Hematology & Oncology , Department of Medicine 1995 -
Senior Scientist (C), O'Neal Comprehensive Cancer Center , School of Medicine 2019 -

Selected Publications

Academic Article

Year	Title	Altmetric
2019	Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia 2019
2019	Mobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost Implications 2019
2018	Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood 2018
2018	Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2 2018
2018	Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant 2018
2018	Late mortality after autologous blood or marrow transplantation in childhood: A Blood or Marrow Transplant Survivor Study-2 report 2018
2018	Two cases and a review of graft-versus-host disease and the role of hepatitis C treatment in liver transplant patients 2018
2017	Safety of repeated un-manipulated peripheral blood stem cell haploidentical transplant for graft failure 2017
2016	In vitro pre-clinical validation of suicide gene modified anti-CD33 redirected chimeric antigen receptor T-cells for acute myeloid leukemia 2016
2016	Acute myofascitis as a manifestation of chronic graft-versus-host disease 2016
2016	Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features 2016
2012	How we closed the gap between red blood cell utilization and whole blood collections in our institution 2012
2012	Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients 2012
2007	Successful treatment of T-cell prolymphocytic leukemia with full-intensity conditioning followed by matched unrelated donor allogeneic stem cell transplantation 2007
2006	Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: Determination of the best diagnostic approach 2006
2006	Improved Outcomes in Intermediate- and High-Risk Aggressive Non-Hodgkin Lymphoma after Autologous Hematopoietic Stem Cell Transplantation Substituting Intravenous for Oral Busulfan in a Busulfan, Cyclophosphamide, and Etoposide Preparative Regimen 2006
2006	High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: Long-term follow-up 2006
2004	Adoptive Immunotherapy with Allogeneic Epstein-Barr Virus (EBV)-Specific Cytotoxic T-Lymphocytes for Recurrent, EBV-Positive Hodgkin Disease 2004
2003	High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma 2003
2002	Fungal brain abscess in transplant recipients: Epidemiologic, microbiologic, and clinical features 2002
2002	A limited sampling strategy for pharmacokinetic directed therapy with intravenous busulfan 2002
2001	Fatal sickle cell crisis after granulocyte colony-stimulating factor administration [1] 2001
2001	Invasive mold infections in allogeneic bone marrow transplant recipients 2001
2000	Adoptive immunotherapy with allogeneic EBV CTL for organ transplant patients with ebv induced lymphoproliferative disease 2000
2000	Diagnosis of gastrointestinal graft-versus-host disease 2000
2000	A phase I-II trial to examine the toxicity of CMV- and EVB-specific cytotoxic T lymphocytes when used for prophylaxis against EVB and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants 2000
2000	Myeloablative chemotherapy for recurrent aggressive oligodendroglioma 2000
1997	Bone marrow transplantation for non-Hodgkin's lymphoma: A review 1997
1996	Malignancy-associated pulmonary veno-occlusive disease: Report of a case following autologous bone marrow transplantation and review 1996
1995	Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors 1995
1994	Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma 1994
1993	A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors 1993
1993	Durable complete remission in a patient with refractory mediastinal non-seminomatous germ cell tumor after tandem high-dose chemotherapy and autologous bone marrow transplantation 1993
1993	Immunotoxins for the therapy of graft versus host disease. 1993